T-cell replete haploidentical bone marrow transplantation and post-transplant cyclophosphamide for patients with inborn errors

Ítems similars

• Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide
  per: Goldsmith, Scott R., et al.
  Publicat: (2016)
• Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide
  per: Solomon, Scott R., et al.
  Publicat: (2016)
• Caspofungin for primary antifungal prophylaxis after T‐cell–replete haploidentical stem cell transplantation with post‐transplant cyclophosphamide
  per: Mariotti, Jacopo, et al.
  Publicat: (2019)
• Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis
  per: Crocchiolo, R., et al.
  Publicat: (2015)
• HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
  per: Fuchs, EJ
  Publicat: (2015)